Medicalgorithmics S.A. (MDG.WA)
PLN 17.1
(3.89%)
PLN 17.1
(3.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 43.09 Million PLN | -31.28% |
| 2022 | 62.71 Million PLN | -47.98% |
| 2021 | 120.56 Million PLN | 7.9% |
| 2020 | 111.73 Million PLN | -35.74% |
| 2019 | 173.87 Million PLN | -12.81% |
| 2018 | 199.4 Million PLN | -1.94% |
| 2017 | 203.35 Million PLN | 58.97% |
| 2016 | 127.92 Million PLN | 159.31% |
| 2015 | 49.33 Million PLN | 66.02% |
| 2014 | 29.71 Million PLN | 89.29% |
| 2013 | 15.69 Million PLN | 43.2% |
| 2012 | 10.96 Million PLN | 88.83% |
| 2011 | 5.8 Million PLN | 41.33% |
| 2010 | 4.1 Million PLN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.9 Million PLN | -15.8% |
| 2024 Q1 | 7.01 Million PLN | -44.03% |
| 2023 Q4 | 12.53 Million PLN | 31.06% |
| 2023 Q2 | 9.7 Million PLN | -14.04% |
| 2023 Q1 | 11.29 Million PLN | -39.18% |
| 2023 Q3 | 9.56 Million PLN | -1.43% |
| 2023 FY | 43.09 Million PLN | -31.28% |
| 2022 Q3 | 17.42 Million PLN | -34.79% |
| 2022 Q1 | 28.78 Million PLN | -6.96% |
| 2022 FY | 62.71 Million PLN | -47.98% |
| 2022 Q4 | 18.56 Million PLN | 6.51% |
| 2022 Q2 | 26.72 Million PLN | -7.14% |
| 2021 Q3 | 30.59 Million PLN | 10.58% |
| 2021 Q2 | 27.66 Million PLN | -11.8% |
| 2021 Q1 | 31.36 Million PLN | 14.15% |
| 2021 FY | 120.56 Million PLN | 7.9% |
| 2021 Q4 | 30.93 Million PLN | 1.12% |
| 2020 FY | 111.73 Million PLN | -35.74% |
| 2020 Q3 | 25.08 Million PLN | 8.62% |
| 2020 Q1 | 36.07 Million PLN | -4.1% |
| 2020 Q4 | 27.47 Million PLN | 9.52% |
| 2020 Q2 | 23.09 Million PLN | -35.97% |
| 2019 Q3 | 42.15 Million PLN | -7.15% |
| 2019 Q4 | 37.61 Million PLN | -10.77% |
| 2019 FY | 173.87 Million PLN | -12.81% |
| 2019 Q1 | 48.69 Million PLN | -14.46% |
| 2019 Q2 | 45.4 Million PLN | -6.77% |
| 2018 Q1 | 44.49 Million PLN | -11.92% |
| 2018 FY | 199.4 Million PLN | -1.94% |
| 2018 Q4 | 56.92 Million PLN | 16.72% |
| 2018 Q3 | 48.77 Million PLN | -0.91% |
| 2018 Q2 | 49.21 Million PLN | 10.62% |
| 2017 Q4 | 50.51 Million PLN | 0.41% |
| 2017 Q1 | 41.44 Million PLN | 19.42% |
| 2017 FY | 203.35 Million PLN | 58.97% |
| 2017 Q2 | 61.09 Million PLN | 47.41% |
| 2017 Q3 | 50.3 Million PLN | -17.67% |
| 2016 Q3 | 40.39 Million PLN | 6.06% |
| 2016 FY | 127.92 Million PLN | 159.31% |
| 2016 Q4 | 34.7 Million PLN | -14.07% |
| 2016 Q1 | 14.73 Million PLN | 6.78% |
| 2016 Q2 | 38.08 Million PLN | 158.38% |
| 2015 FY | 49.33 Million PLN | 66.02% |
| 2015 Q1 | 10.93 Million PLN | 24.02% |
| 2015 Q4 | 13.8 Million PLN | 12.35% |
| 2015 Q3 | 12.28 Million PLN | -0.19% |
| 2015 Q2 | 12.3 Million PLN | 12.6% |
| 2014 Q1 | 5.94 Million PLN | 22.52% |
| 2014 Q2 | 6.59 Million PLN | 10.93% |
| 2014 Q3 | 8.36 Million PLN | 26.91% |
| 2014 Q4 | 8.81 Million PLN | 5.37% |
| 2014 FY | 29.71 Million PLN | 89.29% |
| 2013 Q3 | 3.85 Million PLN | 3.12% |
| 2013 FY | 15.69 Million PLN | 43.2% |
| 2013 Q2 | 3.73 Million PLN | 14.38% |
| 2013 Q1 | 3.26 Million PLN | 12.42% |
| 2013 Q4 | 4.84 Million PLN | 25.97% |
| 2012 Q4 | 2.9 Million PLN | 6.99% |
| 2012 Q1 | 2.27 Million PLN | 0.0% |
| 2012 FY | 10.96 Million PLN | 88.83% |
| 2012 Q2 | 3.07 Million PLN | 35.42% |
| 2012 Q3 | 2.71 Million PLN | -11.73% |
| 2011 FY | 5.8 Million PLN | 41.33% |
| 2010 FY | 4.1 Million PLN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Adiuvo Investments S.A. | 990 Thousand PLN | -4253.333% |
| Genomtec S.A. | 1000.00 PLN | -4309700.0% |
| Medinice S.A. | 225 Thousand PLN | -19054.667% |
| Synektik Spólka Akcyjna | 624.79 Million PLN | 93.102% |